AAAAAA
Results: 1-25/688
Authors:
MIMAKI T
Citation: T. Mimaki, CLINICAL-PHARMACOLOGY AND THERAPEUTIC DRUG-MONITORING OF ZONISAMIDE, Therapeutic drug monitoring, 20(6), 1998, pp. 593-597
Authors:
MORRIS RG
Citation: Rg. Morris, DELIVERY OF THERAPEUTIC DRUG-MONITORING SERVICES - SURVEY OF AUSTRALASIAN CLINICAL-PHARMACOLOGY LABORATORIES, Therapeutic drug monitoring, 20(6), 1998, pp. 598-601
Authors:
POU L
BRUNET M
BILBAO I
ANDREU H
ANDRES I
LOPEZ R
MARGARIT C
RIMOLA T
CORBELLA J
Citation: L. Pou et al., THERAPEUTIC DRUG-MONITORING OF TACROLIMUS IN LIVER-TRANSPLANTATION, PHASE-III FK506 MULTICENTER SPANISH STUDY-GROUP - A 2-YEAR FOLLOW-UP, Therapeutic drug monitoring, 20(6), 1998, pp. 602-606
Authors:
AUCLAIR B
SIROIS G
NGOC AH
DUCHARME MP
Citation: B. Auclair et al., POPULATION PHARMACOKINETICS OF NITROGLYCERIN AND OF ITS 2 METABOLITESAFTER A SINGLE 24-HOUR APPLICATION OF A NITROGLYCERIN TRANSDERMAL MATRIX DELIVERY SYSTEM, Therapeutic drug monitoring, 20(6), 1998, pp. 607-611
Authors:
YASUHARA M
IGA T
ZENDA H
OKUMURA K
OGUMA T
YANO Y
HORI R
Citation: M. Yasuhara et al., POPULATION PHARMACOKINETICS OF VANCOMYCIN IN JAPANESE PEDIATRIC-PATIENTS, Therapeutic drug monitoring, 20(6), 1998, pp. 612-618
Authors:
MAY TW
RAMBECK B
JURGES U
BLANKENHORN V
JURGENS U
Citation: Tw. May et al., COMPARISON OF TOTAL AND FREE PHENYTOIN SERUM CONCENTRATIONS MEASURED BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND STANDARD TDX ASSAY - IMPLICATIONS FOR THE PREDICTION OF FREE PHENYTOIN SERUM CONCENTRATIONS, Therapeutic drug monitoring, 20(6), 1998, pp. 619-623
Authors:
YUAN YS
LI K
ZHAO FL
Citation: Ys. Yuan et al., RELATIVE BIOLOGIC AVAILABILITY AND PHARMACOKINETICS OF ALBUTEROL PREPARATIONS IN HEALTHY CHINESE, Therapeutic drug monitoring, 20(6), 1998, pp. 624-627
Authors:
FACCIOLA G
AVENOSO A
SPINA E
PERUCCA E
Citation: G. Facciola et al., INDUCING EFFECT OF PHENOBARBITAL ON CLOZAPINE METABOLISM IN PATIENTS WITH CHRONIC-SCHIZOPHRENIA, Therapeutic drug monitoring, 20(6), 1998, pp. 628-630
Authors:
COMETS E
MENTRE F
POUSSET F
DIQUET B
MONTALESCOT G
ANKRI A
MALLET A
LECHAT P
Citation: E. Comets et al., MODELING INR DATA TO PREDICT MAINTENANCE FLUINDIONE DOSAGE, Therapeutic drug monitoring, 20(6), 1998, pp. 631-639
Authors:
MOLLGARD L
TIDEFELT U
SUNDMANENGBERG B
LOFGREN C
LEHMAN S
PAUL C
Citation: L. Mollgard et al., HIGH SINGLE-DOSE OF MITOXANTRONE AND CYTARABINE IN ACUTE NONLYMPHOCYTIC LEUKEMIA - A PHARMACOKINETIC AND CLINICAL-STUDY, Therapeutic drug monitoring, 20(6), 1998, pp. 640-645
Authors:
TSERNG KY
MCPEAK RJ
DEJAK I
TSERNG K
Citation: Ky. Tserng et al., PREVENTION OF TRICYCLIC ANTIDEPRESSANT ADSORPTION LOSS WITH DIETHYLAMINE DURING SOLVENT EVAPORATION, Therapeutic drug monitoring, 20(6), 1998, pp. 646-651
Authors:
POTTER JM
DONNELLY A
Citation: Jm. Potter et A. Donnelly, CARBAMAZEPINE-10,11-EPOXIDE IN THERAPEUTIC DRUG-MONITORING, Therapeutic drug monitoring, 20(6), 1998, pp. 652-657
Authors:
DASGUPTA A
HAVLIK D
Citation: A. Dasgupta et D. Havlik, ELEVATED FREE FOSPHENYTOIN CONCENTRATIONS IN UREMIC SERA - UREMIC TOXINS HIPPURIC-ACID AND INDOXYL SULFATE DO NOT ACCOUNT FOR THE IMPAIRED PROTEIN-BINDING OF FOSPHENYTOIN, Therapeutic drug monitoring, 20(6), 1998, pp. 658-662
Authors:
DATTA P
DASGUPTA F
Citation: P. Datta et F. Dasgupta, INTERFERENCE FROM DIGITOXIN-LIKE IMMUNOREACTIVE FACTORS REDUCED IN A NEW MONOCLONAL CHEMILUMINESCENT DIGITOXIN ASSAY, Therapeutic drug monitoring, 20(6), 1998, pp. 663-668
Authors:
HOETELMANS RMW
PROFIJT M
MEENHORST PL
MULDER JW
VANHEESWIJK RPG
BEIJNEN JH
Citation: Rmw. Hoetelmans et al., COTRIMOXAZOLE AND STAVUDINE INTERFERENCE IN A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS FOR DIDANOSINE IN HUMAN PLASMA, Therapeutic drug monitoring, 20(6), 1998, pp. 669-672
Authors:
MEATHERALL R
FRASER AD
Citation: R. Meatherall et Ad. Fraser, COMPARISON OF 4 IMMUNOASSAYS FOR THE DETECTION OF LORAZEPAM IN URINE, Therapeutic drug monitoring, 20(6), 1998, pp. 673-675
Authors:
BRUNET M
POU L
MANZANARES C
PALACIOS G
CORBELLA J
Citation: M. Brunet et al., MULTICENTER COMPARISON OF FIRST-GENERATION AND 2ND-GENERATION IMX TACROLIMUS MICROPARTICLE ENZYME IMMUNOASSAYS IN LIVER AND KIDNEY-TRANSPLANTATION, Therapeutic drug monitoring, 20(6), 1998, pp. 676-679
Authors:
RAINES DA
YUSUF A
JABAK MH
AHMED WS
KARCIOGLU ZA
ELYAZIGI A
Citation: Da. Raines et al., SIMULTANEOUS HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ANALYSIS OF AZITHROMYCIN AND 2 OF ITS METABOLITES IN HUMAN TEARS AND PLASMA, Therapeutic drug monitoring, 20(6), 1998, pp. 680-684
Authors:
BEAL JL
JONES CE
TAYLOR PJ
TETT SE
Citation: Jl. Beal et al., EVALUATION OF AN IMMUNOASSAY (EMIT) FOR MYCOPHENOLIC-ACID IN PLASMA FROM RENAL-TRANSPLANT RECIPIENTS COMPARED WITH A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ASSAY, Therapeutic drug monitoring, 20(6), 1998, pp. 685-690
Authors:
TAYLOR PJ
JONES CE
DODDS HM
HOGAN NS
JOHNSON AG
Citation: Pj. Taylor et al., PLASMA INDOMETHACIN ASSAY USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ELECTROSPRAY TANDEM MASS-SPECTROMETRY - APPLICATION TO THERAPEUTIC DRUG-MONITORING AND PHARMACOKINETIC STUDIES, Therapeutic drug monitoring, 20(6), 1998, pp. 691-696
Authors:
KUDO S
MIZOOKU Y
MIYAMOTO G
ODOMI M
SOGAWA Y
SUGAI T
Citation: S. Kudo et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ELECTROSPRAY TANDEM MASS-SPECTROMETRY FOR THE MEASUREMENT OF 1-(3,4-DICHLOROBENZYL)-5-OCTYLBIGUANIDEIN HUMAN SERUM, Therapeutic drug monitoring, 20(6), 1998, pp. 697-705
Authors:
MAURER HH
KRAEMER T
ARLT JW
Citation: Hh. Maurer et al., SCREENING FOR THE DETECTION OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS, THEIR METABOLITES, AND AT-II RECEPTOR ANTAGONISTS, Therapeutic drug monitoring, 20(6), 1998, pp. 706-713
Authors:
REYMOND JM
DESMEULES J
Citation: Jm. Reymond et J. Desmeules, SODIUM STIBOGLUCONATE (PENTOSTAN) OVERDOSE IN A PATIENT WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME, Therapeutic drug monitoring, 20(6), 1998, pp. 714-716
Authors:
MAHMOOD I
Citation: I. Mahmood, IS 10 MILLIGRAMS SELEGILINE ESSENTIAL AS AN ADJUNCT THERAPY FOR THE SYMPTOMATIC TREATMENT OF PARKINSONS-DISEASE, Therapeutic drug monitoring, 20(6), 1998, pp. 717-721
Authors:
CASTANEDAHERNANDEZ G
PEREZURIZAR J
MEDEIROS M
Citation: G. Castanedahernandez et al., CURRENT BIOEQUIVALENCE CRITERIA ARE ADEQUATE FOR ORAL CYCLOSPORINE-A FORMULATIONS, Therapeutic drug monitoring, 20(6), 1998, pp. 722-723